content

Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as...

LANXESS completes sale of ARLANXEO to Saudi Aramco

Specialty chemicals company LANXESS , December 31, 2018, completed the sale of its remaining 50 percent interest in the rubber company ARLANXEO to Saudi...

North Estonia Medical Centre expands Clinerion’s Patient Network Explorer hospital network in Estonia

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia,...

A special event organized by Turkish Cargo for IATA CEIV Pharma Workshop

Turkish Cargo organized a Special event titled 'Turkish Cargo & IATA CEIV Pharma Workshop’ for the leading pharmaceutical companies, officials from IATA, agents and...

New Study Findings Show Mixture of DuPont Probiotic Strains and Lactoferrin Reduces Common Cause of Vaginal Discomfort

New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture of probiotic strains and lactoferrin could aid in reducing...

India’s growing biopharma market: monoclonal antibodies R&D and production Designing sterile connection systems

Monoclonal antibodies (MAbs) have been extraordinary tools in the field of bioscience due to their high level of specificity and selective binding ability. ...

WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read